Evoke Pharma (EVOK) Competitors $2.90 +0.15 (+5.27%) As of 12:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EVOK vs. ABVC, NRSN, COCP, PHIO, INAB, CLRB, ME, MBRX, UPXI, and IMNNShould you be buying Evoke Pharma stock or one of its competitors? The main competitors of Evoke Pharma include ABVC BioPharma (ABVC), NeuroSense Therapeutics (NRSN), Cocrystal Pharma (COCP), Phio Pharmaceuticals (PHIO), IN8bio (INAB), Cellectar Biosciences (CLRB), 23andMe (ME), Moleculin Biotech (MBRX), Upexi (UPXI), and Imunon (IMNN). These companies are all part of the "pharmaceutical products" industry. Evoke Pharma vs. ABVC BioPharma NeuroSense Therapeutics Cocrystal Pharma Phio Pharmaceuticals IN8bio Cellectar Biosciences 23andMe Moleculin Biotech Upexi Imunon Evoke Pharma (NASDAQ:EVOK) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, community ranking, earnings and risk. Which has more risk and volatility, EVOK or ABVC? Evoke Pharma has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, ABVC BioPharma has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Which has higher earnings and valuation, EVOK or ABVC? Evoke Pharma has higher revenue and earnings than ABVC BioPharma. ABVC BioPharma is trading at a lower price-to-earnings ratio than Evoke Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvoke Pharma$10.25M0.42-$7.79M-$4.40-0.66ABVC BioPharma$509.59K32.05-$10.52M-$0.47-2.20 Does the media refer more to EVOK or ABVC? In the previous week, Evoke Pharma had 2 more articles in the media than ABVC BioPharma. MarketBeat recorded 4 mentions for Evoke Pharma and 2 mentions for ABVC BioPharma. ABVC BioPharma's average media sentiment score of 0.46 beat Evoke Pharma's score of 0.38 indicating that ABVC BioPharma is being referred to more favorably in the news media. Company Overall Sentiment Evoke Pharma Neutral ABVC BioPharma Neutral Do insiders & institutionals hold more shares of EVOK or ABVC? 11.4% of ABVC BioPharma shares are held by institutional investors. 6.1% of Evoke Pharma shares are held by insiders. Comparatively, 11.9% of ABVC BioPharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is EVOK or ABVC more profitable? Evoke Pharma has a net margin of -71.32% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat Evoke Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Evoke Pharma-71.32% -308.49% -53.66% ABVC BioPharma -1,619.65%-104.94%-56.81% Does the MarketBeat Community believe in EVOK or ABVC? Evoke Pharma received 360 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformEvoke PharmaOutperform Votes36057.97% Underperform Votes26142.03% ABVC BioPharmaN/AN/A SummaryEvoke Pharma and ABVC BioPharma tied by winning 7 of the 14 factors compared between the two stocks. Get Evoke Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVOK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVOK vs. The Competition Export to ExcelMetricEvoke PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.32M$6.72B$5.49B$7.97BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-0.267.3622.6118.58Price / Sales0.42241.71397.51103.15Price / CashN/A65.8538.1834.62Price / Book-0.316.486.704.26Net Income-$7.79M$143.43M$3.22B$248.31M7 Day Performance11.78%1.69%1.26%1.34%1 Month Performance15.34%6.58%3.73%3.92%1 Year Performance-43.38%-2.63%15.82%5.33% Evoke Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVOKEvoke Pharma0.5775 of 5 stars$2.90+5.3%N/A-50.0%$4.32M$10.25M-0.264Analyst ForecastNews CoverageABVCABVC BioPharma0.7598 of 5 stars$0.87+2.1%N/A-15.2%$13.77M$509,788.00-1.0130Earnings ReportGap DownNRSNNeuroSense Therapeutics1.1257 of 5 stars$1.00-3.2%N/A-27.4%$13.67MN/A-1.5610Short Interest ↓COCPCocrystal Pharma2.4954 of 5 stars$1.34+1.9%$7.00+424.2%-4.4%$13.58MN/A-0.7210Gap UpPHIOPhio Pharmaceuticals2.5262 of 5 stars$2.83+3.7%$4.00+41.3%-69.4%$13.52MN/A-0.2610Upcoming EarningsINABIN8bio3.6073 of 5 stars$0.17+3.3%$6.00+3,510.1%-83.4%$13.51MN/A-0.2220Upcoming EarningsShort Interest ↓Gap UpCLRBCellectar Biosciences1.7394 of 5 stars$0.29-2.9%$12.50+4,207.4%-91.9%$13.37MN/A-0.1710News CoverageGap UpME23andMeN/A$0.50-35.3%N/A-95.0%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeMBRXMoleculin Biotech2.9511 of 5 stars$0.95+8.6%$6.00+531.4%-78.9%$13.30MN/A0.0020Short Interest ↓News CoverageUPXIUpexi0.9718 of 5 stars$9.89+330.0%N/A+9.4%$13.07M$18.63M0.00130Short Interest ↑High Trading VolumeIMNNImunon2.7247 of 5 stars$0.89-0.2%$21.50+2,319.8%-35.9%$12.99M$500,000.00-0.4730Short Interest ↓ Related Companies and Tools Related Companies ABVC Alternatives NRSN Alternatives COCP Alternatives PHIO Alternatives INAB Alternatives CLRB Alternatives ME Alternatives MBRX Alternatives UPXI Alternatives IMNN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVOK) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVOK Stock Free EVOK Stock Alerts